Rosegay A - Search Results

1

[3H]L-654,284 as a probe of the central alpha 2 adrenoceptor.

Randall WC, Huff JR, Vacca JP, Guare JP, Chen R, Rosegay A, Baldwin JJ. Randall WC, et al. Among authors: rosegay a. Naunyn Schmiedebergs Arch Pharmacol. 1988 Jul;338(1):47-52. doi: 10.1007/BF00168811. Naunyn Schmiedebergs Arch Pharmacol. 1988. PMID: 2907099

2

Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand.

Chang RS, Chen TB, Bock MG, Freidinger RM, Chen R, Rosegay A, Lotti VJ. Chang RS, et al. Among authors: rosegay a. Mol Pharmacol. 1989 Jun;35(6):803-8. Mol Pharmacol. 1989. PMID: 2733696

3

Synthesis and antihypertensive activity of some ester progenitors of methyldopa.

Saari WS, Freedman MB, Hartman RD, King SW, Raab AW, Randall WC, Engelhardt EL, Hirschmann R, Rosegay A, Ludden CT, Scriabine A. Saari WS, et al. Among authors: rosegay a. J Med Chem. 1978 Aug;21(8):746-53. doi: 10.1021/jm00206a006. J Med Chem. 1978. PMID: 691000

4

Metabolic disposition studies on simvastatin, a cholesterol-lowering prodrug.

Vickers S, Duncan CA, Chen IW, Rosegay A, Duggan DE. Vickers S, et al. Among authors: rosegay a. Drug Metab Dispos. 1990 Mar-Apr;18(2):138-45. Drug Metab Dispos. 1990. PMID: 1971563

5

Ophiobolin M and analogues, noncompetitive inhibitors of ivermectin binding with nematocidal activity.

Tsipouras A, Adefarati AA, Tkacz JS, Frazier EG, Rohrer SP, Birzin E, Rosegay A, Zink DL, Goetz MA, Singh SB, Schaeffer JM. Tsipouras A, et al. Among authors: rosegay a. Bioorg Med Chem. 1996 Apr;4(4):531-6. doi: 10.1016/0968-0896(96)00036-3. Bioorg Med Chem. 1996. PMID: 8735840

6

Evidence for a 1,2-hydride shift in the microsomal metabolism of the heterocycle L-158,338, a nonpeptide angiotensin II receptor antagonist.

Stearns RA, Miller RR, Arison BH, Rosegay A, Smith JL, Mantlo NB, Chiu SH. Stearns RA, et al. Among authors: rosegay a. Drug Metab Dispos. 1993 Jul-Aug;21(4):670-6. Drug Metab Dispos. 1993. PMID: 8104127

7

Mechanism-based inactivation of alanine racemase by 3-halovinylglycines.

Thornberry NA, Bull HG, Taub D, Wilson KE, Giménez-Gallego G, Rosegay A, Soderman DD, Patchett AA. Thornberry NA, et al. Among authors: rosegay a. J Biol Chem. 1991 Nov 15;266(32):21657-65. J Biol Chem. 1991. PMID: 1939194 Free article.

8

Metabolism of the TRH analog L-pyro-2-aminoadipyl-L-histidyl-[3H]-L-thiazolidine-4-carboxamide (MK-771) in gut and brain tissue of rats: the implications for its bioavailability.

Vickers S, Duncan CA, Arison BH, Ramjit HG, Rosegay A, Nutt RF, Veber DF. Vickers S, et al. Among authors: rosegay a. Drug Metab Dispos. 1983 Mar-Apr;11(2):147-51. Drug Metab Dispos. 1983. PMID: 6133720

9

Disposition and metabolism of finasteride in dogs.

Carlin JR, Christofalo P, Arison BH, Ellsworth RE, Rosegay A, Miller RR, Chiu SH, VandenHeuvel WJ. Carlin JR, et al. Among authors: rosegay a. Drug Metab Dispos. 1997 Jan;25(1):100-9. Drug Metab Dispos. 1997. PMID: 9010636

10

Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.

Vincent SH, Painter SK, Krieter PA, Colletti AE, Lyszack E, Rosegay A, Dean D, Luffer-Atlas D, Miller RR, Cioffe C, Chiu SH. Vincent SH, et al. Among authors: rosegay a. Drug Metab Dispos. 1996 Dec;24(12):1369-77. Drug Metab Dispos. 1996. PMID: 8971144

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters